What is the role of Ticagrelor? For many people, Ticagrelor probably doesn't know it, and here's the introduction to it:
Tickgray is a new, selective, small-molecule anticoagulant. The drug can be reversible effect on vascular smooth muscle cells (VSMC) on purine 2 receptor subtype (purinoceptor 2, P2) P2Y12, don't need a metabolic activation, to adenosine diphosphate (ADP) has obvious inhibitory effect on platelet aggregation, and oral use catch-up effect quickly, can effectively improve symptoms of patients with acute coronary heart disease (CHD). Unlike thiophene and pyridine drugs, the P2Y12 receptor is a reversible inhibitor for the P2Y12 receptor, so it is especially true for patients who need to be reoperated after an initial anticoagulation treatment.
Want to know more please visit the website: http://www.pharmaceutiucal-materials.com/
No comments:
Post a Comment